134 related articles for article (PubMed ID: 38825783)
21. Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.
Yang M; Zhang L; Hong G; Li Y; Li G; Qian W; Xiong H; Bai T; Song J; Hou X
J Gastroenterol Hepatol; 2020 May; 35(5):795-805. PubMed ID: 31674052
[TBL] [Abstract][Full Text] [Related]
22. Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome.
Sundin J; Aziz I; Nordlander S; Polster A; Hu YOO; Hugerth LW; Pennhag AAL; Engstrand L; Törnblom H; Simrén M; Öhman L
Sci Rep; 2020 Jan; 10(1):593. PubMed ID: 31953505
[TBL] [Abstract][Full Text] [Related]
23. Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion.
Camilleri M; Carlson P; Acosta A; Busciglio I
Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G10-20. PubMed ID: 25930081
[TBL] [Abstract][Full Text] [Related]
24. Mucosal Microbiome Profiles Polygenic Irritable Bowel Syndrome in Mestizo Individuals.
Arredondo-Hernández R; Schmulson M; Orduña P; López-Leal G; Zarate AM; Alanis-Funes G; Alcaraz LD; Santiago-Cruz R; Cevallos MA; Villa AR; Ponce-de-León Rosales S; López-Vidal Y;
Front Cell Infect Microbiol; 2020; 10():72. PubMed ID: 32266159
[TBL] [Abstract][Full Text] [Related]
25. A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome.
Codling C; O'Mahony L; Shanahan F; Quigley EM; Marchesi JR
Dig Dis Sci; 2010 Feb; 55(2):392-7. PubMed ID: 19693670
[TBL] [Abstract][Full Text] [Related]
26. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO
Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583
[TBL] [Abstract][Full Text] [Related]
27. Ecological and network analyses identify four microbial species with potential significance for the diagnosis/treatment of ulcerative colitis (UC).
Li W; Sun Y; Dai L; Chen H; Yi B; Niu J; Wang L; Zhang F; Luo J; Wang K; Guo R; Li L; Zou Q; Ma ZS; Miao Y
BMC Microbiol; 2021 May; 21(1):138. PubMed ID: 33947329
[TBL] [Abstract][Full Text] [Related]
28. Bile Acids and Microbiome Among Individuals With Irritable Bowel Syndrome and Healthy Volunteers.
Kamp KJ; Cain KC; Utleg A; Burr RL; Raftery D; Luna RA; Shulman RJ; Heitkemper MM
Biol Res Nurs; 2021 Jan; 23(1):65-74. PubMed ID: 32666807
[TBL] [Abstract][Full Text] [Related]
29. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota.
Noor SO; Ridgway K; Scovell L; Kemsley EK; Lund EK; Jamieson C; Johnson IT; Narbad A
BMC Gastroenterol; 2010 Nov; 10():134. PubMed ID: 21073731
[TBL] [Abstract][Full Text] [Related]
30. Differences in gut microbiota and fecal bile acids between Caucasian and Hispanic children and young adults with ulcerative colitis.
Aboud Syriani L; Parsana R; Durazo-Arvizu RA; Michail S
Physiol Rep; 2023 Jun; 11(12):e15752. PubMed ID: 37344396
[TBL] [Abstract][Full Text] [Related]
31. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.
Li Y; Hong G; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
Pharmacol Res; 2020 Sep; 159():104936. PubMed ID: 32470562
[TBL] [Abstract][Full Text] [Related]
32. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.
Bajer L; Kverka M; Kostovcik M; Macinga P; Dvorak J; Stehlikova Z; Brezina J; Wohl P; Spicak J; Drastich P
World J Gastroenterol; 2017 Jul; 23(25):4548-4558. PubMed ID: 28740343
[TBL] [Abstract][Full Text] [Related]
33. Increased Ileal Immunoglobulin A Production and Immunoglobulin A-Coated Bacteria in Diarrhea-Predominant Irritable Bowel Syndrome.
Liu Y; Yuan X; Li L; Lin L; Zuo X; Cong Y; Li Y
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00146. PubMed ID: 32352710
[TBL] [Abstract][Full Text] [Related]
34. Gut microbiota contributes to the distinction between two traditional Chinese medicine syndromes of ulcerative colitis.
Zhang YL; Cai LT; Qi JY; Lin YZ; Dai YC; Jiao N; Chen YL; Zheng L; Wang BB; Zhu LX; Tang ZP; Zhu RX
World J Gastroenterol; 2019 Jul; 25(25):3242-3255. PubMed ID: 31333315
[TBL] [Abstract][Full Text] [Related]
35. Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome.
Ivashkin V; Poluektov Y; Kogan E; Shifrin O; Sheptulin A; Kovaleva A; Kurbatova A; Krasnov G; Poluektova E
PLoS One; 2021; 16(6):e0252930. PubMed ID: 34115808
[TBL] [Abstract][Full Text] [Related]
36. Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome.
Ringel-Kulka T; Choi CH; Temas D; Kim A; Maier DM; Scott K; Galanko JA; Ringel Y
Am J Gastroenterol; 2015 Sep; 110(9):1339-46. PubMed ID: 26303129
[TBL] [Abstract][Full Text] [Related]
37. Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome.
Bolte LA; Vich Vila A; Imhann F; Collij V; Gacesa R; Peters V; Wijmenga C; Kurilshikov A; Campmans-Kuijpers MJE; Fu J; Dijkstra G; Zhernakova A; Weersma RK
Gut; 2021 Jul; 70(7):1287-1298. PubMed ID: 33811041
[TBL] [Abstract][Full Text] [Related]
38. Metabolite profiling reveals the interaction of chitin-glucan with the gut microbiota.
Rodriguez J; Neyrinck AM; Zhang Z; Seethaler B; Nazare JA; Robles Sánchez C; Roumain M; Muccioli GG; Bindels LB; Cani PD; Maquet V; Laville M; Bischoff SC; Walter J; Delzenne NM
Gut Microbes; 2020 Nov; 12(1):1810530. PubMed ID: 32893709
[TBL] [Abstract][Full Text] [Related]
39. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
[No Abstract] [Full Text] [Related]
40. Alterations of the human gut Methanobrevibacter smithii as a biomarker for inflammatory bowel diseases.
Ghavami SB; Rostami E; Sephay AA; Shahrokh S; Balaii H; Aghdaei HA; Zali MR
Microb Pathog; 2018 Apr; 117():285-289. PubMed ID: 29477743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
